2018
DOI: 10.1016/j.atherosclerosis.2018.06.125
|View full text |Cite
|
Sign up to set email alerts
|

The amelioration on the vascular inflammatory response by evogliptin, a novel dipeptidyl peptidase 4 inhibitor via regulation of SIRT1/NF-KAPPAB interaction

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles